Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Surg Proced. Mar 28, 2014; 4(1): 1-8
Published online Mar 28, 2014. doi: 10.5412/wjsp.v4.i1.1
Published online Mar 28, 2014. doi: 10.5412/wjsp.v4.i1.1
Outcomes of continuous flow ventricular assist devices
Shelly Bansal, Division of Thoracic Transplantation, Department of Cardiothoracic Surgery, University of Pittsburgh, Pittsburgh, PA 15260, United States
Chittoor B Sai-Sudhakar, Division of Cardiac Surgery, Department of Surgery, The Ohio State University, Columbus, OH 43210, United States
Bryan A Whitson, Division of Cardiac Surgery, The Collaboration for Organ Perfusion, Protection, Engineering and Regeneration (COPPER) Laboratory, The Ohio State University Wexner Medical Center, Columbus, OH 43210, United States
Author contributions: Bansal S, Sai-Sudhakar CB, and Whitson BA contributed equally to this works authorship and revision.
Correspondence to: Bryan A Whitson, MD, PhD, Division of Cardiac Surgery, The Collaboration for Organ Perfusion, Protection, Engineering and Regeneration (COPPER) Laboratory, The Ohio State University Wexner Medical Center, N-813 Doan Hall, 410 W. 10th Ave., Columbus, OH 43210, United States. bryan.whitson@osumc.edu
Telephone: +1-614-3667414 Fax: +1-614-2932020
Received: November 29, 2013
Revised: January 14, 2014
Accepted: January 17, 2014
Published online: March 28, 2014
Revised: January 14, 2014
Accepted: January 17, 2014
Published online: March 28, 2014
Core Tip
Core tip: Left ventricular assist devices provide a durable, long-term alternative to heart transplant for those with end-stage heart failure. In an era of limited transplant donor supply, axial flow pumps are a viable alternative.